Sexual dysfunction after premenopausal stage I and II breast cancer: do androgens play a role?

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 18554258)

Published in J Sex Med on June 28, 2008

Authors

Judith Alder1, Rosanna Zanetti, Edward Wight, Corinne Urech, Nadine Fink, Johannes Bitzer

Author Affiliations

1: University Hospital Basel, Department Obstetrics and Gynecology, Basel, Switzerland. jalder@uhbs.ch

Articles citing this

Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer (2009) 1.34

Challenges in the gynecologic care of premenopausal women with breast cancer. Mayo Clin Proc (2011) 0.98

Coping with sexual concerns after cancer: the use of flexible coping. Support Care Cancer (2010) 0.96

Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis (2013) 0.95

Sexual dysfunction in young women with breast cancer. Support Care Cancer (2012) 0.91

Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. Support Care Cancer (2009) 0.85

Perceived causes and consequences of sexual changes after cancer for women and men: a mixed method study. BMC Cancer (2015) 0.83

Sexual functioning in young women in the context of breast cancer treatment. Rep Pract Oncol Radiother (2013) 0.81

Feeling well and talking about sex: psycho-social predictors of sexual functioning after cancer. BMC Cancer (2014) 0.80

Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status. Support Care Cancer (2013) 0.79

Importance of sexuality in colorectal cancer: predictors, changes, and response to an intimacy enhancement intervention. Support Care Cancer (2016) 0.78

Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial. BMC Cancer (2015) 0.78

Sexual function in breast cancer patients: a prospective study from Iran. J Exp Clin Cancer Res (2012) 0.78

Has testosterone passed the test in premenopausal women with low libido? A systematic review. Int J Womens Health (2016) 0.75

Sexuality after breast cancer: need for guideline. Iran J Cancer Prev (2012) 0.75

Sexuality after breast cancer: cultural specificities of Tunisian population. Pan Afr Med J (2016) 0.75

Talking about women's sexual health after cancer: Why is it so hard to move the needle? Cancer (2017) 0.75

The relationship between sexual dysfunction and quality of marital relationship in genital and breast cancers women. J Educ Health Promot (2017) 0.75

Sexual concerns of women diagnosed with breast cancer-related lymphedema. Support Care Cancer (2015) 0.75

Subjective sexual well-being and sexual behavior in young women with breast cancer. Support Care Cancer (2013) 0.75

Articles by these authors

Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med (2007) 2.49

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception (2006) 1.90

Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg (2007) 1.90

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol (2009) 1.67

Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update (2009) 1.49

A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry (2011) 1.32

Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer (2007) 1.28

Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer. PLoS One (2011) 1.21

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer (2009) 1.20

Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol (2009) 1.18

Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. J Clin Oncol (2006) 1.18

Women's perceptions and reasons for choosing the pill, patch, or ring in the CHOICE study: a cross-sectional survey of contraceptive method selection after counseling. BMC Womens Health (2013) 1.11

Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod Pathol (2006) 1.09

Tumor size and detection in breast cancer: Self-examination and clinical breast examination are at their limit. Cancer Detect Prev (2008) 1.06

Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet (2007) 1.05

Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res (2008) 1.01

Gender differences in physicians' communicative skills and their influence on patient satisfaction in gynaecological outpatient consultations. Soc Sci Med (2008) 0.98

PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus. Diagn Mol Pathol (2003) 0.98

Methylation signature of lymph node metastases in breast cancer patients. BMC Cancer (2012) 0.98

Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol (2003) 0.97

Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients. Eur J Cancer (2006) 0.96

Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Res (2005) 0.92

Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features. J Surg Oncol (2007) 0.92

Women's sexual desire and arousal disorders. J Sex Med (2010) 0.91

MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod (2010) 0.91

T4 breast cancer under closer inspection: a case for revision of the TNM classification. Breast (2007) 0.91

A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol (2006) 0.90

Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med (2011) 0.89

Identification of antenatal depression in obstetric care. Arch Gynecol Obstet (2011) 0.88

Effects of relaxation on psychobiological wellbeing during pregnancy: a randomized controlled trial. Psychoneuroendocrinology (2010) 0.87

Contraceptive counselling and factors affecting women's contraceptive choices: results of the CHOICE study in Austria. Reprod Biomed Online (2011) 0.87

Emergency hormonal contraception in Switzerland: a comparison of the user profile before and three years after deregulation. Eur J Contracept Reprod Health Care (2009) 0.87

Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Res Treat (2008) 0.86

Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers. J Matern Fetal Neonatal Med (2010) 0.86

Fetal response to abbreviated relaxation techniques. A randomized controlled study. Early Hum Dev (2010) 0.86

Maternal request: a reason for rising rates of cesarean section? Arch Gynecol Obstet (2012) 0.85

Frequency and focus of sexual history taking in male patients--a pilot study conducted among Swiss general practitioners and urologists. J Sex Med (2007) 0.85

Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception (2010) 0.84

Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment. PLoS One (2011) 0.84

Post-traumatic symptoms after childbirth: what should we offer? J Psychosom Obstet Gynaecol (2006) 0.84

Isotonic fluid absorption during hysteroscopy resulting in severe hyperchloremic acidosis. Anesthesiology (2005) 0.84

Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples. Breast Cancer Res (2006) 0.83

Previous birth experience and birth anxiety: predictors of caesarean section on demand? J Psychosom Obstet Gynaecol (2009) 0.83

Review of clinical experience with estradiol in combined oral contraceptives. Contraception (2010) 0.83

Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study. Ann Surg Oncol (2007) 0.82

Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma. J Clin Pathol (2006) 0.81

Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials. Oncology (2009) 0.81

How do obstetric variables influence the dimensions of the birth experience as assessed by Salmon's item list (SIL-Ger)? Eur J Obstet Gynecol Reprod Biol (2004) 0.81

Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction. J Sex Med (2013) 0.81

Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumour Biol (2012) 0.80

Three-dimensional pathological size assessment in primary breast carcinoma. Breast Cancer Res Treat (2008) 0.80

The challenge of talking about sex: the importance of patient-physician interaction. Maturitas (2009) 0.80

Communication skills training in obstetrics and gynaecology: whom should we train? A randomized controlled trial. Arch Gynecol Obstet (2007) 0.80

Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J Surg Oncol (2011) 0.80

Is sex just fun? How sexual activity improves health. J Sex Med (2009) 0.80

Cognitive-behavioural group intervention for climacteric syndrome. Psychother Psychosom (2006) 0.79

Antenatal psychobiological predictors of psychological response to childbirth. J Am Psychiatr Nurses Assoc (2011) 0.79

Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision. Cancer J (2009) 0.79

Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients. Ann Surg Oncol (2013) 0.79

Do gynecologists talk about sexual dysfunction with their patients? J Sex Med (2014) 0.78

Relaxation during pregnancy: what are the benefits for mother, fetus, and the newborn? A systematic review of the literature. J Perinat Neonatal Nurs (2012) 0.78

Breast cancer with non-inflammatory skin involvement: current data on an underreported entity and its problematic classification. Breast (2009) 0.78

Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease. Arch Gynecol Obstet (2010) 0.78

Response to induced relaxation during pregnancy: comparison of women with high versus low levels of anxiety. J Clin Psychol Med Settings (2011) 0.78

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest. Gynecol Endocrinol (2012) 0.78

Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification. Cancer (2005) 0.77

Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC. Cancer Cytopathol (2013) 0.77

Impact of hormone replacement therapy on the histologic subtype of breast cancer. Arch Gynecol Obstet (2008) 0.77

Psychosocial factors and therapeutic approaches in the context of sexual history taking in men: a study conducted among Swiss general practitioners and urologists. J Sex Med (2008) 0.77

Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients? Arch Gynecol Obstet (2009) 0.77

Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b). Hum Pathol (2006) 0.77

50th anniversary of the pill--what does this story teach us? Eur J Contracept Reprod Health Care (2010) 0.77

Internet-based stress management for women with preterm labour--a case-based experience report. Arch Womens Ment Health (2014) 0.77

[Gynecological cancer and sexuality]. Ther Umsch (2011) 0.76

The effect of migration background on obstetric performance in Switzerland. Eur J Contracept Reprod Health Care (2008) 0.76

Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder. J Sex Med (2009) 0.76

Acute stress reactions in the first 3 weeks postpartum: a study of 219 parturients. Eur J Obstet Gynecol Reprod Biol (2006) 0.76

European society of contraception statement on contraception in obese women. Eur J Contracept Reprod Health Care (2014) 0.76

Mammotome: less invasive than ABBI with similar accuracy for early breast cancer detection. World J Surg (2005) 0.75

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Indian J Surg Oncol (2010) 0.75

New advances in urogynecology. Obstet Gynecol Int (2011) 0.75

Center of excellence for sexual medicine. J Sex Med (2013) 0.75

[Sexuality after breast cancer]. Ther Umsch (2010) 0.75

Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in Germany, Austria, and Switzerland. Arch Gynecol Obstet (2015) 0.75

Editorial. Eur J Contracept Reprod Health Care (2016) 0.75

Selective visualization of the Fallopian tube with magnetic resonance imaging. Reprod Biomed Online (2007) 0.75

[Genital cancers in the woman]. Ther Umsch (2011) 0.75